α2-Macroglobulin enhances the clearance of endogenous soluble β- amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons

Journal of Neurochemistry

Volumn 73, Issue 4, 1999, Pages 1393-1398

  Qiu, Zhihua ^a   Strickland, Dudley K ^b   Hyman, Bradley T ^a   Rebeck, G William ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HOLLAND LABORATORY   (United States)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Apolipoprotein E; Immunoblot; Lactoferrin

Indexed keywords

ALPHA 2 MACROGLOBULIN; AMYLOID BETA PROTEIN; CELL SURFACE RECEPTOR; LACTOFERRIN; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; BRAIN CELL; CONTROLLED STUDY; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; TRANSGENIC MOUSE; ANIMAL; BRAIN CORTEX; CELL CULTURE; EMBRYO; FEMALE; GENETICS; HUMAN; KINETICS; METABOLISM; NERVE CELL; PHYSIOLOGY;

ALPHA-MACROGLOBULINS; AMYLOID BETA-PROTEIN; ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; EMBRYO; FEMALE; HUMANS; KINETICS; LDL-RECEPTOR RELATED PROTEIN 1; MICE; MICE, TRANSGENIC; NEURONS; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS;

EID: 0032589297     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0731393.x     Document Type: Article

References (38)

1. 2-macroglobulin. J. Cell Biol. 110, 1041-1048.
2. Blacker D., Wilcox M. A., Laird N. M., Rodes L., Horvath S. M., Go R. C. P., Perry R., Watson B., Bassett S. S., McInnis M. G., Albert M. S., Hyman B. T., and Tanzi R. E. (1998) Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet. 19, 357-360.
3. Bu G. and Rennke S. (1996) Receptor-associated protein is a folding chaperone for low density lipoprotein receptor-related protein. J. Biol. Chem. 271, 22218-22224.
4. Bu G., Maksymovitch E. A., Nerbonne J. M., and Schwartz A. L. (1994) Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J. Biol. Chem. 269, 18521-18528.
5. 2-Macroglobulin as a β-amyloid peptide-binding plasma protein. J. Neurochem. 69, 299-305.
6. 2-Macroglobulin attenuates β-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. J. Neurochem. 70, 1182-1188.
7. Essalmani R., Macq A.-F., Mercken L., and Octave J.-N. (1996) Missense mutations associated with familial Alzheimer's disease in Sweden lead to the production of the amyloid peptide without internalization of its precursor. Biochem. Biophys. Res. Commun. 218, 89-96.
8. Fillebeen C., Dexter D., Mitchell V., Benaissa M., Beauvillain J.-C., Spik G., and Pierce A. (1998) Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment, in Advances in Lactoferrin Research (Spik G., Legrand D., Mazurier J., Pierce A., and Perraudin J.-P., eds), pp. 293-300. Plenum Press, New York.
9. Haass C., Koo E. H., Mellon A., Hung A. Y., and Selkoe D. J. (1992) Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357, 500-503.
10. Haass C., Lemere C., Capell A., Citron M., Seubert P., Schenk D., Lannfelt L., and Selkoe D. J. (1995) The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway. Nat. Med. 1, 1291-1296.
11. Holtzman D. M., Pitas R. E., Kilbridge J., Nathan B., Mahley R. W., Bu G., and Schwartz A. L. (1995) Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. USA 92, 9480-9484.
12. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
13. 2-Macroglobulin associates with β-amyloid peptide and prevents fibril formation. Proc. Natl. Acad. Sci. USA 95, 3275-3280.
14. Ida N., Hartmann T., Pantel J., Schroeder J., Zerfass R., Foerstl H., Sandbrink R., Masters C. L., and Beyreuther K. (1996) Analysis of heterogeneous βA4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive western blot assay. J. Biol. Chem. 271, 22908-22914.
15. Ishiguro M., Imai Y., and Kohsaka S. (1995) Expression and distribution of low density lipoprotein receptor-related protein mRNA in the rat central nervous system. Brain Res. Mol. Brain Res. 33, 37-46.
16. Jordan J., Galindo M. F., Miller R. J., Reardon C. A., Getz G. S., and LaDu M. J. (1998) Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J. Neurosci. 18, 195-204.
17. Kounnas M. Z., Moir R. D., Rebeck G. W., Bush A. I., Argraves W. S., Tanzi R. E., Hyman B. T., and Strickland D. K. (1995) LDL receptor-related protein, a multifunctional apoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell 82, 331-340.
18. Liao A., Nitsch R. M., Greenberg S. M., Finckh U., Blacker D., Albert M., Rebeck G. W., Gomez-Isla T., Clatworthy A., Binetti G., Hock C., Mueller-Thomsen T., Mann U., Zuchowski K., Beisiegel U., Staehelin H., Growdon J. H., Tanzi R. E., and Hyman B. T. (1998) Genetic association of an alpha2-macroglobulin (Val1000Ile) polymorphism and Alzheimer's disease. Hum. Mol. Genet. 7, 1953-1956.
19. Namba Y., Tomonaga M., Kawasaki H., Otomo E., and Ikeda K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541, 163-166.
20. 2-Macroglobulin complexes with and mediates the endocytosis of β-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J. Neurochem. 69, 1904-1911.
21. Osmand A. P. and Switzer R. C. III (1991) Differential distribution of lactoferrin and Alz-50 immunoreactivities in neuritic plaques and neurofibrillary tangles in Alzheimer's disease, in Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies (Iqbal K., McLachlan D. R. C., Winblad B., and Wisniewski H. M., eds), pp. 219-228. John Wiley & Sons, Chichester.
22. Paresce D. M., Ghosh R. N., and Maxfield F. R. (1996) Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17, 553-565.
23. Poirier J., Hess M., May P. C., and Finch C. E. (1991) Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol. Brain Res. 11, 97-106.
24. 2-macroglobulin complex. J. Biol. Chem. 271, 8443-8451.
25. Rebeck G. W., Reiter J. S., Strickland D. K., and Hyman B. T. (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11, 575-580.
26. 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann. Neurol. 37, 211-217.
27. Rebeck G. W., Alonzo N. C., Berezovska O., Harr S. D., Knowles R. B., Growdon J. H., Hyman B. T., and Mendez A. J. (1998) Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes. Exp. Neurol. 149, 175-182.
28. Strauss S., Bauer J., Ganter U., Jonas U., Berger M., and Volk B. (1992) Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab. Invest. 66, 223-230.
29. Strickland D. K., Kounnas M. Z., and Argraves W. S. (1995) LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J. 9, 890-898.
30. Strittmatter W. and Roses A. (1996) Apolipoprotein E and Alzheimer's disease. Annu. Rev. Neurosci. 19, 53-77.
31. Strittmatter W. J., Weisgraber K. H., Huang D., Dong L. M., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D., and Roses A. D. (1993) Binding of human apolipoprotein E to βA4 peptide: isoform specific effects and implications for late onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 8098-8102.
32. Tooyama I., Kawamata T., Akiyama H., Moestrup S. K., Gliemann J., and McGeer P. L. (1993) Immunohistochemical study of α2 macroglobulin receptor in Alzheimer and control postmortem human brain. Mol. Chem. Neuropathol. 18, 153-160.
33. 2-macroglobulin receptor) in human brain. Brain Res. 691, 235-238.
34. Urmoneit B., Prikulis I., Wihl G., D'Urso D., Frank R., Heeren J., Beisiegel U., and Prior R. (1997) Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy. Lab. Invest. 77, 157-166.
35. 2-macroglobulin receptor/low density lipoprotein receptor-related protein. J. Biol. Chem. 267, 9035-9040.
36. Yan S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., and Schmidt A. M. (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691.
37. 1-antichymotrypsin. Int. J. Exp. Clin. Invest. 3, 156-161.
38. Zheng G., Bachinsky D. R., Stamenkovic I., Strickland D. K., Brown D., Andres G., and McCluskey R. T. (1994) Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/α2MR, and the receptor-associated protein (RAP). J. Histochem. Cytochem. 42, 531-542.